Olin Corporation (OLN), Nationstar Mortgage Holdings Inc (NSM): Highlights from Steve Cohen’s Latest Buying Spree

Page 2 of 2

In one of its filings, Point72 also disclosed surging its position in Nationstar Mortgage Holdings Inc (NYSE:NSM) to 5.64 million shares from 718,300 shares reported in the latest 13F. Following the increase, the investor’s stake amasses 5.2% of the company’s outstanding common stock. Nationstar Mortgage Holdings Inc (NYSE: NSM) is a $1.90 billion real estate services company, whose stock slid by almost 40% since the beginning of the year. Nevertheless, the last round of 13F filings showed a significant surge in popularity of the company among the funds we track as 31 funds disclosed holding over $2.05 billion worth of stock, versus 17 investors with $2.18 billion a quarter earlier. By far, the largest shareholder of Nationstar Mortgage Holdings Inc (NYSE:NSM) is Michael Novogratz’s Fortress Investment Group, which owns around 67.58 million shares, representing more than 70% of the company. Billionaire Ken Griffin’s Citadel Investment Group is also bullish on the company, as it raised the stake by 1.30 million shares to 1.36 million shares during the first quarter.

And last, but not least, the investor disclosed boosting its stake in the small cap company BioDelivery Sciences International, Inc. (NASDAQ:BDSI). The passive stake contains 2.89 million shares, up from 7,200 shares disclosed in the latest 13F filing, and represents 5.4% of the company’s outstanding stock. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is engaged in the development and commercialization of pharmaceutical products in the areas of pain management and addiction. The company’s stock has lost 35% since the beginning of the year and in May a number of several analysts reduced their price targets, including Cantor Fitzgerald, FBR & Co and Roth Capital, who reduced their targets to $12.00, $18.00 and $14.00 respectively. However, all three analysts maintained bullish ‘Buy’ and ‘Outperform’ ratings. In addition, in May, Kevin Kotler‘s healthcare-focused fund Broadfin Capital raised its stake in BioDelivery Sciences International, Inc. (NASDAQ:BDSI) to 3.89 million shares from 2.25 million shares held previously. Millennium Management is also a shareholder of BioDelivery with 1.86 million shares as of the end of March.

Disclosure: none

Page 2 of 2